New research from our group provides more evidence that psilocybin, the active ingredient in magic mushrooms, can improve creative thinking, empathy, and subjective well-being. Read more here, here ,and here.
Author: natashamason
The Ethical and Ecological Considerations of Inhaling Bufotoxins from Incilius Alvarius – Malin Uthaug
Malin Uthaug, PhD student in our department, recently discussed the ethical considerations of inhaling bufotoxins from Incilius Alvarius. Read her opinions on this practice here
Een microdoses psychedelica om beter te functioneren? – Kim Kuypers
Kim Kuypers spoke with NPO Radio 1, about LSD, microdosing, and our ongoing microdosing trial. Listen to the podcast here.
Wim Riedel: link between university and industry
On 15 February Wim will bid farewell to his career at Maastricht University. Prof. Wim Riedel: Drummer, cyclist, pilot and Professor of Experimental Psychopharmacology at the Faculty of Psychology and Neuroscience (FPN). Read more about Wim's career and contribution to psychopharmacology here.
Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
Amsterdam Psychedelic Research Association 02/06/18 In the last decade, there has been a renewed scientific interest in the utility of psychedelics. Increasing evidence suggests that psychedelics like ayahuasca and psilocybin may have potential therapeutic value for disorders like depression, PTSD, and anxiety. The focus of such investigations has been on psychedelics capacity to reduce symptoms… Continue reading Psychedelics & Cognitive Flexibility: Therapeutic Implications – Natasha Mason
